QUANTITATIVE FACTOR ALLOCATION REPORT

Aggressive 2-Week Trading Portfolio: Dec 8-19, 2025

Analysis Date: 2025-12-07 Portfolio Budget: €1,271.97 Target: 3-4x SPY Performance Max Acceptable Loss: 10% Risk Profile: Aggressive (Beta Target: 1.5-2.0) Broker: DEGIRO (€2 per trade, no fractional shares) Positions: 2-3 maximum


EXECUTIVE SUMMARY

Based on quantitative factor scoring and mean-variance optimization, we recommend a 3-stock portfolio with 95.5% capital utilization and €50.99 cash buffer. The portfolio is expected to deliver 4.8x SPY performance over the 2-week period with a 95% Value-at-Risk of -4.87%, well within the 10% maximum loss constraint.

Key Portfolio Metrics:


1. QUANTITATIVE FACTOR SCORING MATRIX

Factor Weights for 2-Week Aggressive Strategy:

Factor Weight Rationale
Momentum 30% Highest weight for short-term trading
Volatility 25% Risk management and beta targeting
Growth 15% Earnings/revenue momentum
Value 10% Downside protection
Quality 10% Financial health
Catalyst 10% News/events impact

Stock Scores (1-5 Scale):

Ticker Price Beta Sector Momentum Volatility Growth Value Quality Catalyst Composite
AEO $23.09 1.42 Consumer 5.00 4.00 4.20 3.50 2.50 3.25 4.05
MCHP $65.81 1.46 Tech 5.00 3.50 4.00 2.75 2.75 3.90 3.92
CRSP $56.88 1.73 Healthcare 3.00 4.00 3.50 3.00 3.25 3.40 3.39
EXPE $263.43 1.44 Consumer 3.00 3.50 3.20 3.00 3.25 3.25 3.21
GMED $91.10 1.07 Healthcare 3.00 3.00 3.50 3.00 3.25 3.40 3.14
URBN $75.69 1.20 Consumer 3.00 3.00 3.20 3.00 3.00 3.25 3.05
KGC $27.28 1.20 Materials 3.00 3.00 3.00 3.25 3.00 3.15 3.04
ANF $94.87 1.17 Consumer 2.75 2.00 3.70 4.00 2.00 3.50 2.83

Note: AEO and MCHP show exceptional momentum scores (5.0/5.0) driven by strong recent returns (+8.66% week, +35.03% month for AEO; +23.17% week, +17.99% month for MCHP).


2. RECOMMENDED PORTFOLIO ALLOCATION

Optimal 3-Stock Portfolio:

Stock Allocation Rationale
AEO (American Eagle) 34.7% Highest composite score (4.05), strong momentum, retail holiday season boost
MCHP (Microchip Tech) 34.1% Strong momentum, tech sector growth, recent breakout pattern
CRSP (CRISPR Therapeutics) 31.2% Highest beta (1.73), healthcare catalyst potential, diversification

Portfolio Characteristics:


3. POSITION SIZING & TRADE EXECUTION

Budget Breakdown:

Trade Instructions:

Stock Shares Price (€) Allocation Value (€) Order Type
AEO 20 €21.24 34.7% €424.86 Market Order
MCHP 7 €60.55 34.1% €423.82 Market Order
CRSP 7 €52.33 31.2% €366.31 Market Order

Total Position Value: €1,214.99

Important Notes:

  1. No fractional shares - DEGIRO constraint respected
  2. €2 per trade cost accounted for
  3. Market orders recommended for immediate execution
  4. Execute all 3 trades simultaneously to maintain target allocation

4. RISK MANAGEMENT & STOP-LOSS LEVELS

Portfolio Risk Metrics:

Metric Value Constraint Status
Expected 2-week Return 1.45% Target: 0.9-1.2% (3-4x SPY) ✓ EXCEEDS
95% Value-at-Risk -4.87% Max: -10.0% ✓ WITHIN
Portfolio Beta 1.53 Target: 1.5-2.0 ✓ WITHIN
2-week Volatility 3.84% - Acceptable
Max Drawdown Potential ~8-10% Based on stop-losses Managed

Individual Stop-Loss Recommendations:

Stock Current Price Stop Price Stop % Risk per Share Rationale
AEO $23.09 (€21.24) $21.17 (€19.47) 8.3% €1.77 Higher volatility retail stock
MCHP $65.81 (€60.55) $61.68 (€56.75) 6.3% €3.80 Tech with moderate volatility
CRSP $56.88 (€52.33) $52.00 (€47.84) 8.6% €4.49 High beta biotech stock

Stop-Loss Implementation:

  1. Place stops as GTC (Good Till Cancelled) orders
  2. Use mental stops if DEGIRO doesn't support advanced orders
  3. Monitor daily for any fundamental changes
  4. Adjust stops if volatility changes significantly

5. 2-WEEK HORIZON CONSIDERATIONS

Macroeconomic Factors:

  1. Fed Meeting (Dec 9-10): Allocated 15% weight in catalyst scoring
  2. Holiday Season: Retail stocks (AEO) get 10% holiday boost
  3. Year-End Positioning: Institutional flows may benefit high-momentum names
  4. Tax-Loss Harvesting: Some selling pressure possible, but momentum should prevail

Sector-Specific Catalysts:

Time Horizon Adjustments:


6. MONITORING & ADJUSTMENT PROTOCOL

Daily Monitoring Checklist:

  1. Price Action: Check if any position hits stop-loss
  2. News Flow: Monitor for sector-specific catalysts
  3. Market Sentiment: Watch VIX and overall market direction
  4. Volume Confirmation: Ensure volume supports price moves

Adjustment Triggers:

  1. Stop-loss hit: Exit position, redistribute to remaining stocks
  2. +10% gain in any position: Consider taking partial profits
  3. Fundamental deterioration: News/earnings surprises
  4. Market regime change: Significant shift in volatility or correlation

Exit Strategy:


7. THEORETICAL FRAMEWORK & METHODOLOGY

Based on "The Elements of Quantitative Investing":

  1. Chapter 2: Univariate Returns - Momentum and volatility estimation
  2. Chapter 3: What Is Performance? - Expected return and risk metrics
  3. Chapter 4: Linear Models of Returns - Factor model construction
  4. Chapter 9: Portfolio Management - Mean-variance optimization
  5. Chapter 10: Beyond Simple MVO - Constraints and estimation error

Key Quantitative Principles Applied:


8. LIMITATIONS & ASSUMPTIONS

Model Limitations:

  1. Limited historical data for some stocks in research files
  2. Simplified correlation estimation using beta similarity
  3. Normal distribution assumption for VaR calculation
  4. Static factor weights (not adaptive to market conditions)

Key Assumptions:

  1. USD/EUR rate: 0.92 (current approximate)
  2. SPY 2-week baseline: 0.30% return
  3. Annual volatility base: 20% (scaled to 2 weeks)
  4. Trading cost structure: €2 flat fee per trade

Sensitivity Analysis:


9. CONCLUSION & RECOMMENDATION

Final Recommendation: EXECUTE PORTFOLIO

This quantitatively optimized portfolio meets all specified constraints:

Next Steps:

  1. Execute all 3 trades on market open Dec 8
  2. Set stop-loss orders immediately after execution
  3. Monitor daily using checklist above
  4. Prepare for exit on Dec 19 close

Risk-Reward Assessment:


Report Generated: 2025-12-07 Analysis Tool: Quantitative Factor Scoring System Reference: "The Elements of Quantitative Investing" framework

This report is for informational purposes only. Past performance is not indicative of future results. Always conduct your own due diligence before trading.